rs34313873

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002863.5(PYGL):​c.2416A>T​(p.Ile806Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0166 in 1,614,030 control chromosomes in the GnomAD database, including 274 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 14 hom., cov: 32)
Exomes 𝑓: 0.017 ( 260 hom. )

Consequence

PYGL
NM_002863.5 missense

Scores

3
11
4

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 8.02
Variant links:
Genes affected
PYGL (HGNC:9725): (glycogen phosphorylase L) This gene encodes a homodimeric protein that catalyses the cleavage of alpha-1,4-glucosidic bonds to release glucose-1-phosphate from liver glycogen stores. This protein switches from inactive phosphorylase B to active phosphorylase A by phosphorylation of serine residue 15. Activity of this enzyme is further regulated by multiple allosteric effectors and hormonal controls. Humans have three glycogen phosphorylase genes that encode distinct isozymes that are primarily expressed in liver, brain and muscle, respectively. The liver isozyme serves the glycemic demands of the body in general while the brain and muscle isozymes supply just those tissues. In glycogen storage disease type VI, also known as Hers disease, mutations in liver glycogen phosphorylase inhibit the conversion of glycogen to glucose and results in moderate hypoglycemia, mild ketosis, growth retardation and hepatomegaly. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014384419).
BP6
Variant 14-50905520-T-A is Benign according to our data. Variant chr14-50905520-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 258841.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-50905520-T-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0122 (1866/152334) while in subpopulation NFE AF= 0.0178 (1208/68026). AF 95% confidence interval is 0.0169. There are 14 homozygotes in gnomad4. There are 895 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 14 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PYGLNM_002863.5 linkuse as main transcriptc.2416A>T p.Ile806Leu missense_variant 20/20 ENST00000216392.8 NP_002854.3
PYGLNM_001163940.2 linkuse as main transcriptc.2314A>T p.Ile772Leu missense_variant 19/19 NP_001157412.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PYGLENST00000216392.8 linkuse as main transcriptc.2416A>T p.Ile806Leu missense_variant 20/201 NM_002863.5 ENSP00000216392 P1P06737-1
PYGLENST00000532462.5 linkuse as main transcriptc.2379+2751A>T intron_variant 1 ENSP00000431657
PYGLENST00000544180.6 linkuse as main transcriptc.2314A>T p.Ile772Leu missense_variant 19/192 ENSP00000443787 P06737-2

Frequencies

GnomAD3 genomes
AF:
0.0123
AC:
1868
AN:
152216
Hom.:
14
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00425
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0121
Gnomad ASJ
AF:
0.00691
Gnomad EAS
AF:
0.0125
Gnomad SAS
AF:
0.0164
Gnomad FIN
AF:
0.00960
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0178
Gnomad OTH
AF:
0.0119
GnomAD3 exomes
AF:
0.0133
AC:
3351
AN:
251450
Hom.:
24
AF XY:
0.0138
AC XY:
1882
AN XY:
135906
show subpopulations
Gnomad AFR exome
AF:
0.00326
Gnomad AMR exome
AF:
0.00752
Gnomad ASJ exome
AF:
0.00744
Gnomad EAS exome
AF:
0.0106
Gnomad SAS exome
AF:
0.0172
Gnomad FIN exome
AF:
0.0115
Gnomad NFE exome
AF:
0.0167
Gnomad OTH exome
AF:
0.0153
GnomAD4 exome
AF:
0.0171
AC:
24955
AN:
1461696
Hom.:
260
Cov.:
33
AF XY:
0.0171
AC XY:
12468
AN XY:
727150
show subpopulations
Gnomad4 AFR exome
AF:
0.00290
Gnomad4 AMR exome
AF:
0.00783
Gnomad4 ASJ exome
AF:
0.00777
Gnomad4 EAS exome
AF:
0.0141
Gnomad4 SAS exome
AF:
0.0169
Gnomad4 FIN exome
AF:
0.0122
Gnomad4 NFE exome
AF:
0.0185
Gnomad4 OTH exome
AF:
0.0178
GnomAD4 genome
AF:
0.0122
AC:
1866
AN:
152334
Hom.:
14
Cov.:
32
AF XY:
0.0120
AC XY:
895
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.00423
Gnomad4 AMR
AF:
0.0121
Gnomad4 ASJ
AF:
0.00691
Gnomad4 EAS
AF:
0.0125
Gnomad4 SAS
AF:
0.0164
Gnomad4 FIN
AF:
0.00960
Gnomad4 NFE
AF:
0.0178
Gnomad4 OTH
AF:
0.0118
Alfa
AF:
0.0154
Hom.:
5
Bravo
AF:
0.0113
TwinsUK
AF:
0.0173
AC:
64
ALSPAC
AF:
0.0187
AC:
72
ESP6500AA
AF:
0.00363
AC:
16
ESP6500EA
AF:
0.0169
AC:
145
ExAC
AF:
0.0138
AC:
1672
Asia WGS
AF:
0.0140
AC:
48
AN:
3478
EpiCase
AF:
0.0158
EpiControl
AF:
0.0154

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycogen storage disease, type VI Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 20, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 03, 2023- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 10, 2016- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
not provided Benign:2
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024PYGL: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.49
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Uncertain
0.0
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.46
.;T
Eigen
Uncertain
0.43
Eigen_PC
Uncertain
0.51
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D;D
MetaRNN
Benign
0.014
T;T
MetaSVM
Uncertain
0.59
D
MutationAssessor
Pathogenic
3.6
.;H
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-1.8
N;N
REVEL
Uncertain
0.63
Sift
Uncertain
0.024
D;D
Sift4G
Uncertain
0.034
D;D
Polyphen
0.0060
.;B
Vest4
0.35
MutPred
0.29
.;Gain of catalytic residue at I806 (P = 0.0913);
MPC
0.16
ClinPred
0.077
T
GERP RS
6.1
Varity_R
0.85
gMVP
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34313873; hg19: chr14-51372238; COSMIC: COSV99046576; COSMIC: COSV99046576; API